JP2012502884A5 - - Google Patents

Download PDF

Info

Publication number
JP2012502884A5
JP2012502884A5 JP2011526360A JP2011526360A JP2012502884A5 JP 2012502884 A5 JP2012502884 A5 JP 2012502884A5 JP 2011526360 A JP2011526360 A JP 2011526360A JP 2011526360 A JP2011526360 A JP 2011526360A JP 2012502884 A5 JP2012502884 A5 JP 2012502884A5
Authority
JP
Japan
Prior art keywords
disease
compound
pharmaceutically acceptable
acceptable salt
intervening substituent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011526360A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012502884A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2009/001302 external-priority patent/WO2010037207A1/en
Publication of JP2012502884A publication Critical patent/JP2012502884A/ja
Publication of JP2012502884A5 publication Critical patent/JP2012502884A5/ja
Pending legal-status Critical Current

Links

JP2011526360A 2008-09-16 2009-09-16 選択的グリコシダーゼ阻害剤およびその使用 Pending JP2012502884A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9747008P 2008-09-16 2008-09-16
US61/097,470 2008-09-16
PCT/CA2009/001302 WO2010037207A1 (en) 2008-09-16 2009-09-16 Selective glycosidase inhibitors and uses thereof

Publications (2)

Publication Number Publication Date
JP2012502884A JP2012502884A (ja) 2012-02-02
JP2012502884A5 true JP2012502884A5 (enExample) 2012-07-12

Family

ID=42072983

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011526360A Pending JP2012502884A (ja) 2008-09-16 2009-09-16 選択的グリコシダーゼ阻害剤およびその使用

Country Status (6)

Country Link
US (1) US20110301217A1 (enExample)
EP (1) EP2344452A4 (enExample)
JP (1) JP2012502884A (enExample)
AU (1) AU2009299073B2 (enExample)
CA (1) CA2737267A1 (enExample)
WO (1) WO2010037207A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006220187B2 (en) * 2005-03-01 2012-11-08 Simon Fraser University Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
EP2057171A4 (en) 2006-08-31 2010-04-21 Univ Fraser Simon SELECTIVE GLYCOSIDASE INHIBITORS AND APPLICATIONS THEREOF
JP5687194B2 (ja) * 2008-08-01 2015-03-18 サイモン フレイザー ユニバーシティ 選択的グリコシダーゼインヒビターおよびその使用
US9120781B2 (en) 2010-05-11 2015-09-01 Simon Fraser University Selective glycosidase inhibitors and uses thereof
LT2627672T (lt) * 2010-10-11 2018-12-10 Biogen International Neuroscience Gmbh Žmogaus antikūnai prieš tau baltymą
WO2012061927A1 (en) 2010-11-08 2012-05-18 Alectos Therapeutics, Inc. Selective glycosidase inhibitors and uses thereof
US8901087B2 (en) 2010-11-08 2014-12-02 Merck Sharp & Dohme Corp. Selective glycosidase inhibitors and uses thereof
TW201249848A (en) 2010-11-08 2012-12-16 Merck Sharp & Dohme Selective glycosidase inhibitors and uses thereof
BR112013016179A2 (pt) 2010-12-23 2018-07-10 Alectos Therapeutics Inc inibidores seletivos da glicosidase e usos dos mesmos.
GB201103526D0 (en) * 2011-03-02 2011-04-13 Summit Corp Plc Selective glycosidase inhibitors and uses thereof
WO2012126091A1 (en) 2011-03-24 2012-09-27 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
US9718854B2 (en) 2011-03-31 2017-08-01 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
WO2013000086A1 (en) 2011-06-27 2013-01-03 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
WO2013000085A1 (en) 2011-06-27 2013-01-03 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
MX364602B (es) 2011-06-27 2019-05-02 Alectos Therapeutics Inc Inhibidores selectivos de glicosidasa y usos de los mismos.
CN104395323B (zh) 2012-05-08 2017-08-01 默沙东公司 可透过性糖苷酶抑制剂及其用途
EP2890676B1 (en) 2012-08-31 2018-12-05 Alectos Therapeutics Inc. Glycosidase inhibitors and uses thereof
EP2890675A4 (en) * 2012-08-31 2016-01-13 Alectos Therapeutics Inc GLYCOSIDASE INHIBITORS AND USES THEREOF
EP2914604A4 (en) 2012-10-31 2016-07-20 Alectos Therapeutics Inc GLYCOSIDASE INHIBITORS AND USES THEREOF
WO2024083820A1 (en) 2022-10-18 2024-04-25 Institut National de la Santé et de la Recherche Médicale Method and composition for determining the level of o-glcnacylation in horses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8900719D0 (en) * 1989-01-13 1989-03-08 Nycomed As Compounds
US5451679A (en) * 1994-03-08 1995-09-19 G. D. Searle & Co. 2-chloro and 2-bromo derivatives of 1,5-iminosugars
FR2817472B1 (fr) * 2000-12-06 2003-01-03 Oreal Composition de teinture d'oxydation a base de 1-(4-aminophenyl)pyrrolidines substituees au moins en position 2 et 3 et procede de teinture de mise en oeuvre
WO2003008379A1 (en) * 2001-06-08 2003-01-30 Mitsubishi Chemical Corporation Azasugar compounds
JP2007518814A (ja) * 2004-01-20 2007-07-12 ザ・スクリップス・リサーチ・インスティテュート グリコシダーゼ阻害剤によるほ乳類での変性軟骨症の治療
AU2006220187B2 (en) * 2005-03-01 2012-11-08 Simon Fraser University Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
US7919521B2 (en) * 2005-12-05 2011-04-05 Academia Sinica Five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis therapeutics

Similar Documents

Publication Publication Date Title
JP2014524911A5 (enExample)
JP2014501740A5 (enExample)
JP2015534991A5 (enExample)
JP2011529858A5 (enExample)
JP2011529857A5 (enExample)
JP2010501598A5 (enExample)
WO2008025170B1 (en) Selective glycosidase inhibitors and uses thereof
RU2013134345A (ru) Селективные ингибиторы гликозидазы и их применение
JP6243472B2 (ja) カゼインキナーゼ1デルタ(ck1デルタ)阻害剤
JP6218260B2 (ja) Jak阻害剤としてのアミノピリミジニル化合物
RU2757218C2 (ru) Аминопиразолы в качестве селективных ингибиторов янус-киназы
Zhi et al. Hybrid Antibacterials. DNA polymerase: topoisomerase inhibitors
Bagdanoff et al. Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders
Patel et al. Synthesis of potential antitubercular and antimicrobial s-triazine-based scaffolds via Suzuki cross-coupling reaction
Zhi et al. Synthesis of substituted 6-anilinouracils and their inhibition of DNA polymerase IIIC and Gram-positive bacterial growth
JP2013541596A5 (enExample)
WO2003076437A1 (de) Cdk inhibitorische 2-heteroaryl-pyrimidine, deren herstellung und verwendung als arzneimittel
JP5250553B2 (ja) 2−置換―6−ヘテロ環ピリミドン誘導体
RU2014102232A (ru) Селективные ингибиторы гликозидазы и их применение
RU2015120556A (ru) Ингибиторы гликозидаз и их применения
JP2004505973A (ja) ブラジキニンアンタゴニストとしての1,4−ジヒドロピリジン類
CA2545092A1 (en) Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity
Suresh Kumar et al. Synthesis and pharmacological evaluation of novel 4-isopropylthiazole-4-phenyl-1, 2, 4-triazole derivatives as potential antimicrobial and antitubercular agents
MX2013015085A (es) N-(6-((2r,3s)-3,4-dihidroxibutan-2-iloxi)-2-(4-fluorobenciltio)pi rimidin-4-il)-3-metilacetidina-1-sulfonamida como modulador del receptor de quimiocina.
Krishna et al. Synthesis and antimicrobial assessment of novel coumarins featuring 1, 2, 4-oxadiazole